Perjeta 420mg Injection 14ml
❌ Due to high demand, this product is currently out of stock. New stock will be available shortly.
👉 Click here to Buy Same Salt medicine
Perjeta 420mg Injection is a targeted cancer medicine used under medical supervision to treat certain types of breast cancer, especially when the cancer cells have too much of a protein called HER2. It works by attaching to the HER2 receptor on cancer cells and blocking signals that help those cells grow and divide. By interfering with this growth pathway, Perjeta 420mg Injection can help slow the spread of cancer and improve treatment outcomes when used as part of a cancer treatment plan. It is commonly used with other anti-cancer medicines for HER2-positive breast cancer, including early-stage and metastatic disease. This medicine does not work for all cancers, so testing for HER2 is important before treatment.
Description
Perjeta 420mg Injection is a prescription anticancer medicine used in the treatment of certain types of breast cancer, especially cancers that are driven by overexpression or amplification of the her2 protein. it is a monoclonal antibody, which means it is a laboratory-made protein designed to recognize a specific target on cancer cells. in this case, Perjeta 420mg Injection binds to the her2 receptor, a protein found on the surface of some cancer cells that can promote rapid cell growth and survival. by attaching to this receptor, Perjeta 420mg Injection helps block the signals that tell the cancer cells to grow and divide. it may also help the immune system identify and attack these cells more effectively.
this medicine is not a traditional chemotherapy drug in the usual sense, although it is often given together with other cancer medicines as part of a treatment plan. it is commonly used in combination with other agents such as trastuzumab and chemotherapy for eligible patients with her2-positive breast cancer. because it acts on a specific biological target, Perjeta 420mg Injection is considered a targeted therapy. its use is determined by cancer type, stage of disease, her2 test results, and the overall treatment plan chosen by the oncology team.
Perjeta 420mg Injection is mainly for patients who have her2-positive breast cancer in settings where her2-directed therapy is appropriate, including some early-stage and metastatic cases. it is administered by a healthcare professional in a clinical setting, usually by intravenous infusion. since it can affect the heart and may cause other clinically significant adverse effects, patients receiving Perjeta 420mg Injection require careful monitoring before and during treatment. a doctor or oncologist will decide whether it is suitable based on medical history, tumor characteristics, and other treatments being used.
because cancer care is highly individualized, Perjeta 420mg Injection should never be started, stopped, or combined with other medicines without medical supervision. the expected benefit depends on whether the tumor expresses her2, how far the cancer has progressed, and how the patient tolerates therapy. regular follow-up, imaging, laboratory monitoring, and cardiac assessment are often part of treatment planning.
ingredients
- Perjeta 420mg Injection: the active ingredient and the main therapeutic component. it is a monoclonal antibody that binds to the her2 receptor on cancer cells, helping prevent her2 from pairing with other receptors and reducing growth-promoting signals. this targeted action is what gives the medicine its anticancer benefit in her2-positive disease.
- inactive formulation components: depending on the product presentation, the medicine may also contain stabilizers, buffers, sugars, and salts used to maintain the protein’s stability, ph, and potency during storage and administration. these ingredients do not treat cancer directly, but they help ensure the medicine remains effective and safe to infuse.
- water for injection or reconstitution vehicle: in injectable formulations, sterile water or other approved diluents may be used to prepare the medicine for infusion. this helps deliver the drug safely through intravenous administration under professional supervision.
key uses
- her2-positive breast cancer: Perjeta 420mg Injection is used for cancers that test positive for her2, a marker associated with more aggressive tumor growth. it helps slow the disease by blocking her2-driven signaling pathways.
- early-stage her2-positive breast cancer: in selected patients, it may be used before surgery or after surgery as part of a larger treatment plan to reduce the risk of recurrence and improve long-term outcomes.
- metastatic her2-positive breast cancer: it may be used when breast cancer has spread beyond the breast and nearby lymph nodes. in this setting, it is typically part of combination therapy aimed at controlling disease and delaying progression.
- combination treatment with other cancer medicines: Perjeta 420mg Injection is usually not used alone. it is commonly combined with other her2-targeted therapies and chemotherapy to improve treatment effectiveness in appropriate patients.
how to use
Perjeta 420mg Injection is given as an intravenous infusion in a hospital, infusion center, or oncology clinic by trained healthcare professionals. it is not a self-administered medicine and should not be injected or taken at home unless specifically arranged within a supervised care program. the infusion schedule, duration, and combination medicines depend on the cancer type, stage, and the clinician’s treatment plan. before each dose, the healthcare team may check blood pressure, temperature, symptoms, and other clinical parameters to make sure it is safe to proceed.
patients are often observed during and after the infusion because infusion-related reactions can occur, especially early in treatment. the healthcare team may provide premedications or adjust the infusion rate if needed. it is important to attend every scheduled appointment, since timing matters in cancer therapy and missed visits can affect the treatment plan. patients should tell the care team about any new symptoms such as fever, shortness of breath, chest discomfort, swelling, dizziness, rash, or palpitations before receiving the infusion.
since Perjeta 420mg Injection is part of combination cancer therapy, patients should follow all instructions for the other medicines in the regimen, including chemotherapy agents and supportive treatments. regular monitoring is essential, especially heart function testing when recommended. if the patient feels unwell after an infusion or develops severe symptoms, medical help should be sought promptly rather than waiting for the next appointment.
safety information
- warnings: Perjeta 420mg Injection can cause serious heart-related problems, including decreased left ventricular function and heart failure, especially when used with other her2-directed medicines or certain chemotherapies. it may also cause infusion-related reactions, allergic reactions, and significant diarrhea. because of these risks, cardiac monitoring and close supervision during infusion are often necessary. any symptoms such as chest pain, shortness of breath, fainting, swelling in the legs, or rapid heartbeat should be reported immediately.
- side effects: common side effects may include diarrhea, nausea, fatigue, hair loss, rash, decreased appetite, fever, vomiting, weakness, and infusion-related symptoms such as chills, headache, flushing, or mild breathing discomfort. serious side effects can include severe allergic reactions, heart failure, significant drop in heart function, severe diarrhea leading to dehydration, lung or breathing complications, and low blood cell counts when used with chemotherapy. patients should seek urgent medical care if they develop severe rash, swelling of the face or throat, difficulty breathing, persistent vomiting, or signs of dehydration.
- precautions: patients with a history of heart disease, heart failure, abnormal heart function, high blood pressure, prior exposure to cardiotoxic treatments, or uncontrolled medical conditions need careful evaluation before use. extra caution is also needed in older adults and in patients receiving multiple cancer medicines, since the risk of complications may be higher. Perjeta 420mg Injection should only be used when the cancer is confirmed to be her2-positive, because it is unlikely to help in her2-negative disease.
- pregnancy/breastfeeding: Perjeta 420mg Injection may cause harm to an unborn baby and is generally not recommended during pregnancy unless the potential benefit outweighs the risk. women of childbearing potential may need pregnancy testing before treatment and may be advised to use effective contraception during therapy and for a period afterward, according to medical guidance. breastfeeding is generally not recommended during treatment, because it is not known whether the medicine passes into breast milk and because of the potential risk to the infant.
- interactions: Perjeta 420mg Injection is commonly given with other anticancer medicines, and the combined effects can increase the risk of side effects such as heart problems, diarrhea, or low blood counts. patients should provide a complete list of all prescription drugs, over-the-counter products, vitamins, and herbal supplements to their oncology team. alcohol does not have a known direct interaction, but it may worsen dehydration, nausea, fatigue, or liver-related issues during cancer treatment, so patients should ask their doctor whether alcohol is appropriate.
additional information
- storage: store as directed by the healthcare facility or pharmacy, typically under controlled refrigeration before preparation, and protect from inappropriate heat, light, or freezing. because this is a professionally administered injectable biologic, patients usually do not store it at home. follow the product-specific handling instructions exactly, as improper storage can reduce effectiveness.
- missed dose: if a scheduled infusion is missed, the patient should contact the oncology clinic as soon as possible to reschedule. do not try to make up the dose on your own. the care team will decide the safest timing and whether any changes are needed to the treatment schedule.
- overdose: overdose is uncommon because the medicine is administered by trained professionals in a controlled setting. if too much is given, the main concern is an increased risk of side effects such as infusion reactions, heart-related problems, or severe gastrointestinal symptoms. emergency evaluation and supportive treatment are needed if an overdose is suspected.
- habit forming: no. Perjeta 420mg Injection is not habit forming and does not cause dependence or addiction. it is an anticancer biologic medicine used for a specific medical purpose under supervised treatment.
frequently asked questions
Q: what is Perjeta 420mg Injection used for?
A: Perjeta 420mg Injection is used to treat certain her2-positive breast cancers. it works by blocking the her2 receptor, which helps slow or stop the growth of cancer cells. it is usually given as part of combination therapy rather than alone.
Q: is Perjeta 420mg Injection a chemotherapy medicine?
A: Perjeta 420mg Injection is a targeted monoclonal antibody, not a traditional chemotherapy drug. however, it is often used together with chemotherapy and other her2-targeted medicines to improve treatment results.
Q: how is Perjeta 420mg Injection given?
A: Perjeta 420mg Injection is given by intravenous infusion in a clinic or hospital by healthcare professionals. it is not meant for self-administration at home. the infusion may be monitored closely, especially at the beginning of treatment.
Q: what are the most common side effects of Perjeta 420mg Injection?
A: common side effects include diarrhea, fatigue, nausea, fever, rash, hair loss, vomiting, and infusion-related reactions such as chills or headache. some patients may experience more serious effects, including heart problems or severe allergic reactions.
Q: can Perjeta 420mg Injection affect the heart?
A: yes. Perjeta 420mg Injection can reduce heart function in some patients, particularly when used with certain other cancer medicines. doctors often monitor heart function before and during treatment to reduce this risk.
Q: do i need testing before starting Perjeta 420mg Injection?
A: yes, patients usually need confirmation that the cancer is her2-positive before treatment. doctors may also check heart function and review medical history to make sure the medicine is appropriate and safe.
Q: can Perjeta 420mg Injection be used in pregnancy?
A: Perjeta 420mg Injection may harm an unborn baby and is generally avoided during pregnancy unless a doctor determines that the benefits clearly outweigh the risks. effective contraception is usually recommended during treatment and for a time afterward.
Q: can i breastfeed while receiving Perjeta 420mg Injection?
A: breastfeeding is generally not recommended during treatment with Perjeta 420mg Injection because the risk to the infant is not fully known and may be significant. ask your healthcare provider for advice before breastfeeding.
Q: what should i do if i miss an infusion?
A: if you miss a scheduled infusion, contact your oncology team right away. do not attempt to replace or delay the dose on your own, because the treatment schedule must be adjusted by a professional.
Q: can i take Perjeta 420mg Injection with other cancer medicines?
A: yes, Perjeta 420mg Injection is commonly used with other medicines such as her2-targeted therapies and chemotherapy. the exact combination depends on the patient’s condition and must be decided by the oncology team.
Q: does Perjeta 420mg Injection cause hair loss?
A: hair loss can occur, but it is often related to the chemotherapy medicines given with Perjeta 420mg Injection rather than Perjeta 420mg Injection alone. your cancer team can help explain which side effects are expected from each medicine in the regimen.
Q: how long will i need treatment with Perjeta 420mg Injection?
A: the length of treatment varies depending on whether the cancer is early-stage or metastatic, how well the medicine is working, and how well it is tolerated. your oncologist will determine the appropriate duration based on your response and overall plan.
Q: what symptoms should i report immediately during treatment?
A: report shortness of breath, chest pain, swelling, severe diarrhea, fever, rash, dizziness, fainting, or signs of an allergic reaction such as facial swelling or trouble breathing. these symptoms may require urgent medical attention.
Q: can alcohol be taken with Perjeta 420mg Injection?
A: there is no known direct interaction, but alcohol can worsen nausea, dehydration, fatigue, and overall treatment tolerance. it is best to ask your oncology team whether alcohol is safe for you during therapy.
Q: is Perjeta 420mg Injection safe for all breast cancers?
A: no. Perjeta 420mg Injection is intended for her2-positive breast cancers only. it is not expected to help if the tumor does not overexpress or amplify her2, so testing is essential before use.
Q: why is heart monitoring needed with Perjeta 420mg Injection?
A: because Perjeta 420mg Injection can affect cardiac function, especially in combination with other her2-targeted treatments, doctors may perform heart tests before and during therapy. monitoring helps detect problems early and prevent serious complications.
Q: can Perjeta 420mg Injection cause allergic reactions?
A: yes. as with many infused biologic medicines, Perjeta 420mg Injection can cause infusion-related or allergic reactions. symptoms may include itching, rash, fever, chills, difficulty breathing, or swelling, and these need prompt medical attention.
Q: should i stop other medications before starting Perjeta 420mg Injection?
A: do not stop or start any medication without speaking to your doctor. your oncology team should review all current medicines, including supplements, to avoid interactions and to manage side effects safely.
Q: what if i feel fine after the infusion?
A: even if you feel fine, keep all follow-up appointments and monitoring tests. some side effects, especially heart-related ones, may not be obvious right away and are best found through planned checkups.
Q: who decides if Perjeta 420mg Injection is right for me?
A: an oncologist usually makes this decision based on your cancer subtype, her2 test results, overall health, heart function, and prior treatments. the choice is individualized and should be discussed in detail with your cancer care team.
this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.
At Gem Pharmacy, we make every effort to provide accurate, expert-written, and thoroughly reviewed information related to medicines. However, this information should not be considered a substitute for professional medical advice, diagnosis, or treatment from a qualified doctor.
The purpose of this information is to educate users and improve communication between patients and healthcare professionals. It should not be used to diagnose or treat any condition.
Always consult a certified healthcare professional before taking any medication.
